Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Host dendritic cell infusion with donor lymphocyte infusion for relapsed multiple myeloma after allogeneic transplantation
NL-OMON28206Phase 2Recruiting
- Sponsor
- Multiple Myeloma Research Foundation
- Start
- Mar 2006
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of donor lymphocytes in multiple myeloma (MM), sponsored by Multiple Myeloma Research Foundation. Started Mar 2006; status: recruiting.
02
Drugs
donor lymphocytes
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NL-OMON28206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28206.